On 18 March 2024, IFPMA submitted and delivered statements at the 9th Meeting of the Intergovernmental Negotiating Body (INB). The full submitted statement is below.
Read moreIn response to the threat of future global pandemics, the biopharmaceutical industry developed a set of commitments for equitable access to essential medical countermeasures in future pandemics.
Read moreOn 8 March 2024, IFPMA delivered a statement at the resumed session of the 7th Meeting of the Working Group on Amendments to the International Health Regulations in Geneva, where the focus of discussions was on equity.
Read more